Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience – Page 569

Strange Mathematical Pattern Found in The Cells of The Human Body

From the oxygen-carrying corpuscles in our blood to the branching neurons that govern our thoughts, our body is built of a dazzling variety of cells.

Researchers from institutions in Germany, Canada, Spain, and the US have published a comprehensive study of how many individual cells of each type there are in typical bodies.

Based on an exhaustive analysis of over 1,500 published sources, most adult males contain a total of around 36 trillion cells, while adult females tend to have some 28 trillion cells. A 10-year-old child, by comparison, would have in the region of 17 trillion.

From Human Uniqueness to Mental Imagery: This Week’s Top 5 Neuroscience Insights, September 17, 2023

Summary: New research delves into the distinctive human trait of sequential memory, setting us apart from bonobos. A recent study has also highlighted the joy in chasing passions over accomplishments. Groundbreaking discoveries show the human brain’s computational prowess, mirroring high-powered computers.

Additionally, the footprint of Big Tobacco is evident in the modern American diet through the promotion of hyperpalatable foods. Lastly, understanding the range of mind’s visualization abilities, from hyperphantasia to aphantasia, opens avenues for innovative treatments.

The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab

With the demise of Roche’s gantenerumab in November 2022, the Alzheimer’s disease space became a two-horse race between Eisai and Biogen’s Leqembi (lecanemab) and Eli Lilly’s donanemab. One, Leqembi, received full FDA approval in July; the other, donanemab, is widely expected to secure the agency’s approval before the end of 2023.

With a potential combined market value of $30 billion, BioSpace takes a deep dive into the Phase III data supporting Eisai and Biogen’s Leqembi and Eli Lilly’s investigational donanemab.

Innovative Gene Screening in Human Tissue May Unlock Autism’s Secrets

Summary: Researchers pioneered a groundbreaking method called “CHOOSE” to investigate genes tied to autism spectrum disorder (ASD) within human tissue. This technique allows for simultaneous examination of key transcriptional regulator genes linked to autism in a single organoid.

Utilizing CHOOSE, the team pinpointed mutations in 36 genes known to heighten autism risk, shedding light on how they influence brain development. The revelations from these organoids mirrored clinical observations, underscoring the potential of this method in advancing our understanding of neurodevelopmental disorders.

The Science Behind Apple’s ‘State Of Mind’ Feature, Explained By A Psychologist

Apple’s new “State of Mind” feature in the Health app is more than a tech update; it’s Apple’s foray into helping us understand our emotions. Beyond tracking physical activity with the Apple Watch, the company is now capturing our moods. This, combined with insights from a new Journal app (which Apple says will be woven into our life’s events and multimedia tapestry), aims to give a full picture of our daily experiences, both in body and mind.

Here’s how Apple envisions this feature will play out in real life.

Imagine a vacation in an unfamiliar city. At the start of your day, the Health app prompts you to record your mood. You describe it as “Very Pleasant” and indicate to the app that… More.

Armed with iOS 17 and watchOS 10, iPhone 15 and a number of other Apple devices may soon be able to track your mood. Could this set off the next big trend in mental health support?

Potential Therapeutic Benefit of NAD+ Supplementation for Glaucoma and Age-Related Macular Degeneration

Year 2020 Immortality in eyes achieved with Nad plus 😗😁😘.

Glaucoma and age-related macular degeneration are leading causes of irreversible blindness worldwide with significant health and societal burdens. To date, no clinical cures are available and treatments target only the manageable symptoms and risk factors (but do not remediate the underlying pathology of the disease). Both diseases are neurodegenerative in their pathology of the retina and as such many of the events that trigger cell dysfunction, degeneration, and eventual loss are due to mitochondrial dysfunction, inflammation, and oxidative stress. Here, we critically review how a decreased bioavailability of nicotinamide adenine dinucleotide (NAD; a crucial metabolite in healthy and disease states) may underpin many of these aberrant mechanisms. We propose how exogenous sources of NAD may become a therapeutic standard for the treatment of these conditions.

Brain’s Own THC: Endocannabinoids Are Nature’s Way to Combat Stress

Summary: A recent study illuminates the brain’s unique response to stress: releasing its own cannabinoid molecules akin to THC from cannabis plants.

Centered in the amygdala, these molecules counteract stress alarms originating from the hippocampus, an integral memory and emotion region. This hints at the body’s intrinsic mechanism for stress management.

Disruption in this system might escalate risks for stress-induced psychiatric conditions.

/* */